From baseline to 1 year , the mean visual-acuity letter score ( range , 0 to 100 , with higher scores indicating better visual acuity ; a score of 85 is approximately 20/20 ) improved by 13.3 with aflibercept , by 9.7 with bevacizumab , and by 11.2 with ranibizumab .